Total Payments
$465,987
2024 Payments
$17,608
Companies
52
Transactions
1,138
Medicare Patients
38,952
Medicare Billing
$4.1M
Payment Breakdown by Category
Other$393,216 (84.4%)
Travel$39,604 (8.5%)
Food & Beverage$23,547 (5.1%)
Consulting$9,594 (2.1%)
Education$26.87 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $393,216 | 182 | 84.4% |
| Travel and Lodging | $39,604 | 104 | 8.5% |
| Food and Beverage | $23,547 | 838 | 5.1% |
| Consulting Fee | $9,594 | 10 | 2.1% |
| Education | $26.87 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $213,697 | 210 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $104,840 | 232 | $0 (2024) |
| Lilly USA, LLC | $65,719 | 69 | $0 (2024) |
| Amgen Inc. | $52,080 | 109 | $0 (2024) |
| Esperion Therapeutics, Inc. | $14,280 | 34 | $0 (2024) |
| ABIOMED | $6,143 | 64 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,840 | 120 | $0 (2024) |
| PFIZER INC. | $831.38 | 47 | $0 (2024) |
| Inari Medical, Inc. | $592.04 | 6 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $510.80 | 37 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,608 | 93 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,099) |
| 2023 | $37,245 | 120 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19,471) |
| 2022 | $52,351 | 129 | Boehringer Ingelheim Pharmaceuticals, Inc. ($31,721) |
| 2021 | $37,471 | 98 | Boehringer Ingelheim Pharmaceuticals, Inc. ($11,142) |
| 2020 | $39,542 | 105 | Janssen Pharmaceuticals, Inc ($12,410) |
| 2019 | $126,495 | 211 | Janssen Pharmaceuticals, Inc ($52,205) |
| 2018 | $99,807 | 211 | Boehringer Ingelheim Pharmaceuticals, Inc. ($60,381) |
| 2017 | $55,468 | 171 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27,712) |
All Payment Transactions
1,138 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $23.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $12.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Obesity | ||||||
| 10/24/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $70.07 | General |
| Category: Lithoplasty | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $30.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: DIABETES | ||||||
| 10/09/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Cardiology | ||||||
| 09/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.86 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/24/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Genetic Disease | ||||||
| 09/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $5.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Cardiology | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,200.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 54 | 9,582 | 14,057 | $3.3M | $981,284 |
| 2022 | 55 | 10,133 | 15,927 | $3.6M | $1.1M |
| 2021 | 56 | 9,670 | 14,299 | $3.2M | $947,116 |
| 2020 | 64 | 9,567 | 16,163 | $3.7M | $1.1M |
Total Patients
38,952
Total Services
60,446
Medicare Billing
$4.1M
Procedure Codes
239
All Medicare Procedures & Services
239 procedure records from CMS Medicare Utilization — Page 1 of 10
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 244 | 244 | $972,175 | $262,901 | 27.0% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 243 | 246 | $175,250 | $132,349 | 75.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 1,266 | 1,569 | $281,855 | $129,383 | 45.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 532 | 537 | $509,399 | $67,097 | 13.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 385 | 389 | $201,385 | $48,993 | 24.3% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 71 | 72 | $108,000 | $41,943 | 38.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 103 | 935 | $84,150 | $40,385 | 48.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 195 | 780 | $97,500 | $31,811 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 482 | 500 | $60,000 | $30,099 | 50.2% |
| 78434 | Nuclear medicine study of heart muscle blood flow by pet | Office | 2023 | 216 | 216 | $63,432 | $27,392 | 43.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 2,053 | 2,589 | $147,546 | $24,962 | 16.9% |
| 36475 | Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | Office | 2023 | 16 | 21 | $84,570 | $16,236 | 19.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 76 | 76 | $77,860 | $16,049 | 20.6% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 114 | 114 | $22,800 | $10,962 | 48.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 89 | 89 | $20,470 | $9,199 | 44.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 640 | 693 | $34,620 | $9,058 | 26.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 55 | 59 | $30,630 | $7,358 | 24.0% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 41 | 44 | $27,660 | $7,199 | 26.0% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 122 | 134 | $45,828 | $5,621 | 12.3% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 47 | $8,225 | $4,529 | 55.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 399 | 413 | $37,170 | $4,268 | 11.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 50 | 116 | $8,628 | $3,863 | 44.8% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 15 | 15 | $18,680 | $3,366 | 18.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $6,300 | $3,139 | 49.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 62 | 64 | $15,680 | $3,127 | 19.9% |
About Dr. Agostino Ingraldi, M.D
Dr. Agostino Ingraldi, M.D is a Cardiovascular Disease healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427254432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Agostino Ingraldi, M.D has received a total of $465,987 in payments from pharmaceutical and medical device companies, with $17,608 received in 2024. These payments were reported across 1,138 transactions from 52 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($393,216).
As a Medicare-enrolled provider, Ingraldi has provided services to 38,952 Medicare beneficiaries, totaling 60,446 services with total Medicare billing of $4.1M. Data is available for 4 years (2020–2023), covering 239 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Lafayette, LA
- Active Since 06/26/2007
- Last Updated 10/20/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1427254432
Products in Payments
- JARDIANCE (Drug) $277,026
- XARELTO (Drug) $104,834
- Repatha (Biological) $51,741
- NEXLIZET (Drug) $13,873
- Impella (Device) $6,143
- ENTRESTO (Drug) $1,337
- ELIQUIS (Drug) $836.92
- LifeVest (Device) $510.80
- LEQVIO (Drug) $502.71
- NEXLETOL (Drug) $407.19
- FlowTriever (Device) $324.19
- Livalo (Drug) $316.93
- Corlanor (Drug) $315.84
- BRILINTA (Drug) $307.61
- FLOWTRIEVER CATHETER, S (Device) $267.85
- PRALUENT (Drug) $210.33
- CardioMEMS HF System (Device) $203.96
- Vascepa (Drug) $197.53
- ENDURANT IIS (Device) $194.55
- VERQUVO (Drug) $184.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lafayette
Dr. Ankur Lodha, M.d, M.D
Cardiovascular Disease — Payments: $547,830
Cardiovascular Disease $547,830
Raghotham Patlola, Md, MD
Cardiovascular Disease — Payments: $233,594
Cardiovascular Disease $233,594
Dr. Louis Salvaggio, M.d, M.D
Cardiovascular Disease — Payments: $193,985
Cardiovascular Disease $193,985
Eric Thomassee, Md, MD
Cardiovascular Disease — Payments: $147,529
Cardiovascular Disease $147,529
Wade May, Md, MD
Cardiovascular Disease — Payments: $117,092
Cardiovascular Disease $117,092
Dr. Eoin Donnellan
Cardiovascular Disease — Payments: $45,504
Cardiovascular Disease $45,504